The incidence of Y-T2DM is increasing parallel with the childhood obesity epidemic. The ADA consensus recommends screening for Y-T2DM or prediabetes in asymptomatic overweight youth who have any two additional risk factors (RFs): family history of T2DM in 1st or 2nd degree relatives, minority race/ethnicity, insulin resistance [acanthosis nigricans, polycystic ovary syndrome, hypertension, dyslipidemia, and small for gestational age], and maternal GDM during the child’s gestation. However, the evidence for these recommendations is minimal, if not nonexistent. In an established pediatric obesity registry, OGTT data of 618 youth ˃10 years old, BMI ≥ 85th%, were analyzed to evaluate the prevalence of DG based on the frequency of RFs. Participants were divided into 4 groups according to the number of RFs. Participants were 70% females, 70% Caucasians, 31% with prediabetes, and 5.1% with Y-T2DM. With increasing RFs, the prevalence of normal glucose tolerance (NGT) declined, DG increased, fasting glucose concentration did not change, but fasting insulin concentration increased significantly (Table: mean ± SE). Participants with 1 RF had ∼25% prevalence of DG. The odds for DG with 2, 3 and ≥ 4RFs were 1.6, 1.7, and 2.5 respectively compared to 1 RF (P=0.01).

In conclusion, the prevalence of prediabetes and T2DM in overweight/obese youth is high ∼25% in the presence of only 1 RF, and escalates with increasing number of RFs.

 Obesity + 1 RF (n=45) Obesity + 2 RF (n=165) Obesity + 3 RF (n=223) Obesity + ≥4RF (n=185) P-ANOVA 
Age (years) 13.7 ± 0.3 14.0 ± 0.2 14.3 ± 0.1 14.4 ± 0.2 NS 
Glycemic status (NGT/Dysglycemia), n (%) 34 (75.6 %) / 11 (24.4 %) 1(65.5 %) / 57 (34.5 %) 143 (64.1 %) / 80 (35.9 %) 103 (55.7 %) / 82 (44.3 %) 0.009 
BMI percentile 97.6 ± 0.4 98.0 ± 0.3 98.4 ± 0.2 98.6 ± 0.2 NS 
Fasting glucose (mg/dl) 92.4 ± 1.2 93.9 ± 0.9 94.0 ± 0.9 94.9 ± 1.2 NS 
Fasting insulin (μu/ml) 25.6 ± 2.3 31.0 ± 1.9 34.7 ± 1.6 42.5 ± 2.7 < 0.0001 
OGTT 2-hr. Glucose (mg/dl) 117.6 ± 4.7 125.9 ± 3.0 129.4 ± 2.7 138.4 ± 3.3 0.001 
OGTT 2-hr. Insulin (μU/ml) 121.5 ± 17.6 160.7 ± 11.2 169.9 ± 10.8 217.0 ± 14.3 < 0.0001 
 Obesity + 1 RF (n=45) Obesity + 2 RF (n=165) Obesity + 3 RF (n=223) Obesity + ≥4RF (n=185) P-ANOVA 
Age (years) 13.7 ± 0.3 14.0 ± 0.2 14.3 ± 0.1 14.4 ± 0.2 NS 
Glycemic status (NGT/Dysglycemia), n (%) 34 (75.6 %) / 11 (24.4 %) 1(65.5 %) / 57 (34.5 %) 143 (64.1 %) / 80 (35.9 %) 103 (55.7 %) / 82 (44.3 %) 0.009 
BMI percentile 97.6 ± 0.4 98.0 ± 0.3 98.4 ± 0.2 98.6 ± 0.2 NS 
Fasting glucose (mg/dl) 92.4 ± 1.2 93.9 ± 0.9 94.0 ± 0.9 94.9 ± 1.2 NS 
Fasting insulin (μu/ml) 25.6 ± 2.3 31.0 ± 1.9 34.7 ± 1.6 42.5 ± 2.7 < 0.0001 
OGTT 2-hr. Glucose (mg/dl) 117.6 ± 4.7 125.9 ± 3.0 129.4 ± 2.7 138.4 ± 3.3 0.001 
OGTT 2-hr. Insulin (μU/ml) 121.5 ± 17.6 160.7 ± 11.2 169.9 ± 10.8 217.0 ± 14.3 < 0.0001 

Disclosure

M. Saleh: None. J. Kim: None. C. March: None. S. Yousuf: None. S.A. Arslanian: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.